Medical science says a stent is needed only when the blockage in an artery is more than 80%. However, a recent ...

Reflow Medical has completed enrollment in a clinical trial evaluating its retrievable stent for the treatment of vascular ...

Abbott has returned to the field of bio-absorbable, dissolving stents, and in somewhat uncharted territory. | Abbott has ...

Reflow Medical, Inc. announced the completion of enrollment in the DEEPER REVEAL clinical trial of the Reflow Spur stent.

A former OSF HealthCare doctor was found negligent in his actions when treating the 13-year-old in 2011 when she was an ...

McMeans, a leader in Abbott’s vascular unit, discussed the company’s newly approved stent for the tough-to-treat condition in an interview with MedTech Dive.

In the PREVENT trial, researchers found that adding percutaneous coronary intervention to optimal medical treatment resulted in better patient outcomes.

The data support endovascular therapy with stent implantation as an alternative to bypass surgery in men and women.

First-of-its-kind, Esprit BTK Everolimus Eluting Resorbable Scaffold System is designed to keep treat chronic ...

(RTTNews) - Abbott Laboratories (ABT) Monday announced that the U.S. Food and Drug Administration has approved the Esprit BTK Everolimus Eluting Resorbable Scaffold System for patients suffering from ...

The Central Bureau of Investigation has arrested a senior manager of a medical equipment firm and a nurse in connection with ...

The drug-eluting coronary stent system improves upon previous versions of XIENCE with an enhanced stent design, a new ...